CreatorsPublishersAdvertisers
View more in
Diseases & Treatments

Dr. Mauro on Considerations for Early Treatment Initiation in Myelofibrosis

onclive.com
 2021-08-05

Michael J. Mauro, MD, discusses considerations for early treatment initiation in myelofibrosis. Michael J. Mauro, MD, the leader of the Myeloproliferative Neoplasms Program at Memorial Sloan Kettering Cancer Center, discusses considerations for early treatment initiation in myelofibrosis. Disease progression occurs on a spectrum in myelofibrosis, ranging from asymptomatic disease to...

www.onclive.com

Comments / 0

Comments / 0